MicroRNA-16-5p Inhibits Osteoclastogenesis in Giant Cell Tumor of Bone

Figure 3

TRAP, CK, and MMP9 expression in RANKL-induced BMM osteoclastogenesis treated with miR-16-5p inhibitor or mimics. (a) TRAP, CK, and MMP9 expression in RANKL-induced BMM osteoclastogenesis treated with miR-16-5p inhibitor. (b) TRAP, CK, and MMP9 expression in RANKL-induced BMM osteoclastogenesis treated with miR-16-5p mimics. Mimic represents the agomir for miR-16-5p, inhibitor represents the antagomir for miR-16-5p, mimic control represents the negative control for miR-16-5p mimic, and inhibitor control represents the negative control for miR-16-5p inhibitor. , , and . P values were analyzed using the one-way ANOVA test.

(a)

(b)